Target intelligence / Profile preview

Convulsions

01

Overview

Convulsions are clinical symptoms defined by sudden, involuntary, and paroxysmal contractions of the skeletal muscles, often resulting from abnormal and excessive electrical activity in the brain [1][2]. While the term is frequently used synonymously with 'seizures,' convulsions specifically denote the motoric phase of a seizure event, which can be tonic, clonic, or tonic-clonic in nature [1]. Because convulsions represent a physiological state or clinical phenotype rather than a specific protein or molecular entity, they are not considered a therapeutic target in the traditional pharmacological sense; instead, they serve as the clinical indication for anti-epileptic drugs (AEDs) [3]. These drugs act on various molecular targets, such as the Gamma-aminobutyric acid (GABA) system or voltage-gated ion channels, to restore the balance between excitatory and inhibitory neurotransmission [4]. Etiologies for convulsions are diverse, ranging from chronic conditions like epilepsy to acute triggers such as high fever, metabolic imbalances, or neurovascular insults [2]. Citations: [1] StatPearls: Seizure (https://www.ncbi.nlm.nih.gov/books/NBK430765/); [2] Mayo Clinic: Seizures (https://www.mayoclinic.org/diseases-conditions/seizure/symptoms-causes/syc-20365711); [3] Epilepsy Foundation: What is a Seizure? (https://www.epilepsy.com/what-is-epilepsy/understanding-seizures); [4] NIH: Epilepsy and Seizures (https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures).

Other names
SeizuresTonic-clonic movementsFitsParoxysmsEpileptic fitsSpasms
02

Mechanism of action

Convulsions are clinical manifestations rather than molecular targets; however, medications treat them by modulating targets such as GABA-A receptors (potentiation), voltage-gated sodium channels (blockade), or SV2A proteins (binding) to stabilize neuronal membranes and inhibit excessive firing [1][3].

03

Biological functions

Neuromuscular hyper-excitabilityAbnormal neuronal synchronizationRapid muscle contraction and relaxation
04

Disease associations

EpilepsyFebrile seizuresEclampsiaMeningitisHypoglycemiaDrug withdrawalTraumatic brain injury
05

Safety considerations

Status epilepticusRespiratory depression (medication-induced)Sudden Unexpected Death in Epilepsy (SUDEP)Aspiration pneumoniaHypoxic brain injury
06

Interacting drugs

Diazepam

7 more in the full profile.

07

Biomarkers

Electroencephalogram (EEG) abnormalitiesPost-ictal serum prolactin elevationSerum creatine kinase elevationNeuron-specific enolase (NSE)

Beyond the preview

Go deeper on Convulsions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convulsions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call